Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic Meningiomas
Open Access
- 1 August 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (2) , 661-669
- https://doi.org/10.1016/s0002-9440(10)61737-3
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe
This publication has 48 references indexed in Scilit:
- Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localizationOncogene, 2000
- ?Malignancy? in meningiomasCancer, 1999
- Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor moleculeOncogene, 1998
- Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myelomaBritish Journal of Haematology, 1997
- Detection of TP53 gene mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction/single‐strand conformation polymorphism and dna sequencing techniques on paraffin‐embedded samplesInternational Journal of Cancer, 1995
- Accumulation of wild‐type p53 in meningiomasNeuropathology and Applied Neurobiology, 1995
- Allelic loss at 1 p is associated with tumor progression of meningiomasGenes, Chromosomes and Cancer, 1994
- Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progressionInternational Journal of Cancer, 1994
- Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomasNature Genetics, 1994
- Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous systemMolecular Carcinogenesis, 1993